Drug Profile
Dideoxythymidine
Latest Information Update: 23 Sep 2021
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source; Nonindustrial sources
- Class Antivirals; Nucleosides
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 17 Jul 2001 No-Development-Reported for HIV-1 infections in Japan (Unknown route)
- 17 Jul 2001 No-Development-Reported for HIV-1 infections in USA (Unknown route)